Proton Pump Inhibitor (PPI) Use and Risk of Hip/Femur Fracture

被引：0
|
作者：
Jean, Rosenie Thelus [1 ]
Meyer, Tamra E. [1 ]
Taylor, Lockwood G. [1 ]
Gordon, Geoff E. [2 ]
Coster, Trinka S. [1 ]
机构：
[1] HP& S, Off Surg Gen, CenterDept Army, Silver Spring, MD USA
[2] Oracle Corp, Hlth Sci Global Business Unit, Waltham, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
61
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [31] Use of anti-depressants and the risk of fracture of the hip or femur
    M. W. M. van den Brand
    M. M. Samson
    S. Pouwels
    T. P. van Staa
    B. Thio
    C. Cooper
    H. G. M. Leufkens
    A. C. G. Egberts
    H. J. J. Verhaar
    F. de Vries
    Osteoporosis International, 2009, 20 : 1705 - 1713
  • [32] Use of anti-depressants and the risk of fracture of the hip or femur
    M. W. M. van den Brand
    S. Pouwels
    M. M. Samson
    T. P. van Staa
    B. Thio
    C. Cooper
    H. G. M. Leufkens
    A. C. G. Egberts
    H. J. J. Verhaar
    F. de Vries
    Osteoporosis International, 2009, 20 : 1715 - 1715
  • [33] Use of anti-depressants and the risk of fracture of the hip or femur
    van den Brand, M. W. M.
    Samson, M. M.
    Pouwels, S.
    van Staa, T. P.
    Thio, B.
    Cooper, C.
    Leufkens, H. G. M.
    Egberts, A. C. G.
    Verhaar, H. J. J.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (10) : 1705 - 1713
  • [34] Is a proton pump inhibitor (PPI) the GP's gastroscopy?
    Schneider, H. R.
    SOUTH AFRICAN FAMILY PRACTICE, 2005, 47 (02) : 24 - 29
  • [35] Proton pump inhibitors’ use and risk of hip fracture: a systematic review and meta-analysis
    Salman Hussain
    Ali Nasir Siddiqui
    Anwar Habib
    Md. Sarfaraj Hussain
    Abul Kalam Najmi
    Rheumatology International, 2018, 38 : 1999 - 2014
  • [36] Proton pump inhibitors' use and risk of hip fracture: a systematic review and meta-analysis
    Hussain, Salman
    Siddiqui, Ali Nasir
    Habib, Anwar
    Hussain, Md. Sarfaraj
    Najmi, Abul Kalam
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (11) : 1999 - 2014
  • [37] Proton pump inhibitor (PPI) use in Australia: Evaluating national quality use of medicines initiatives
    Bruno, Claudia
    Pearson, Sallie-Anne
    Daniels, Benjamin
    Buckley, Nicholas
    Zoega, Helga
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 519 - 519
  • [38] Proton-pump inhibitor (PPI) for laryngeal granulomas
    Teraoka, M
    Hasegawa, T
    Saito, M
    Kinishi, M
    Amatsu, M
    BRONCHOLOGY AND BRONCHOESOPHAGOLOGY: STATE OF THE ART, 2001, 1217 : 220 - 224
  • [39] Hip Fracture and Proton Pump Inhibitor Therapy: Balancing the Evidence for Benefit and Harm
    Moayyedi, Paul
    Cranney, Ann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (10) : 2428 - 2431
  • [40] Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study
    Moberg, Louise M. E.
    Nilsson, Peter M.
    Samsioe, Goran
    Borgfeldt, Christer
    MATURITAS, 2014, 78 (04) : 310 - 315
12345